ASCO20: What was the background and study design of the SPARTAN study?

Eric Small | ASCO20 Virtual | Onkologia ja Hematologia | KESÄKUU 3, 2020

Asiantuntija: Eric Small

Eric J. Small, MD and principal investigator of the SPARTAN study here explains the background and study design of the SPARTAN study, where the efficiency and safety of apalutamide for patients with nonmetastatic castration-resistant prostate cancer (nmCRPC).